NCT01627691 - REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

October 8, 2012

Primary Completion Date

May 30, 2014

Study Completion Date

May 13, 2019

Conditions

Transcatheter Aortic Valve Replacement

Interventions

DEVICE

Lotus Valve System

"* bioprosthetic bovine pericardial aortic valve~* delivery system"

Trial Locations (20)

Royal Adelaide Hospital, Adelaide

Prince Charles Hospital, Brisbane

Monash Medical Center, Melbourne

St. Vincent's Hospital, Melbourne

Hôpital Cardiologique CHRU de Lille, Lille

Hôpital Cardiologique de Lyon, Lyon

Institut Cardiovasculaire Paris Sud, Paris

Centre Hôpital Universitaire Rangueil, Toulouse

Clinique Pasteur, Toulouse

Deutsches Herzzentrum München, München

Helios Klinikum Siegburg, Siegburg

Ospedale Ferrarotto, Catania

Erasmus MC - Thorax Center, Rotterdam

Hospital Clinico San Carlos, Madrid

University Hospital of Lund, Lund

INSELSPITAL - Universitätsspital Bern, Bern

Royal Victoria Hospital, Belfast

Royal Sussex County Hospital, Brighton

The General Infirmary, Leeds

Guys and St. Thomas NHS Foundation Trust, London